|
90
|
300
|
9emjA |
Sars-cov-2 methyltransferase nsp10-16 in complex with toyocamycin and m7gpppa (cap0-analog) |
|
65
|
172
|
8azlA |
Structure of sars-cov-2 nsp3 macrodomain in complex with 2'-deoxy-2'-fluoro-adpr |
|
64
|
171
|
8azmA |
Structure of sars-cov-2 nsp3 macrodomain in complex with 8br-adpr |
|
90
|
299
|
8s8wA |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa-rna (cap0-rna) |
|
26
|
116
|
9emlB |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
|
88
|
300
|
9emvA |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
|
95
|
318
|
8vecA |
Deep mutational scanning of sars-cov-2 plpro |
|
24
|
116
|
9emjB |
Sars-cov-2 methyltransferase nsp10-16 in complex with toyocamycin and m7gpppa (cap0-analog) |
|
25
|
114
|
8s8xB |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin and m7gpppa-rna (cap0-rna) |
|
93
|
301
|
8s8xA |
Sars-cov-2 nsp10-16 methyltransferase in complex with toyocamycin and m7gpppa-rna (cap0-rna) |
|
25
|
114
|
8s8wB |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa-rna (cap0-rna) |
|
63
|
172
|
8azpA |
Structure of sars-cov-2 nsp3 macrodomain in complex with beta-methyl-adp |
|
93
|
300
|
9emlA |
Sars-cov-2 methyltransferase nsp10-16 in complex with sam and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
|
24
|
115
|
9emvB |
Sars-cov-2 nsp10-16 methyltransferase in complex with sangivamycin and m7gpppa (cap0-analog)/m7gpppam (cap1-analog) |
|
83
|
300
|
8intA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant |
|
85
|
306
|
8inwA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant in complex with inhibitor nirmatrelvir |
|
86
|
306
|
8inuA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant in complex with inhibitor nirmatrelvir |
|
85
|
300
|
8inqA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant |
|
77
|
301
|
8uhoA |
Crystal structure of sars cov-2 3cl protease in complex with gsk4365096a |
|
84
|
301
|
8inxA |
Crystal structure of sars-cov-2 main protease (mpro) g15s mutant in complex with inhibitor ensitrelvir |
|
83
|
301
|
8inyA |
Crystal structure of sars-cov-2 main protease (mpro) k90r mutant in complex with inhibitor ensitrelvir |
|
248
|
928
|
8gwmA |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
|
81
|
300
|
8ya5A |
Mpro from sars-cov-2 |
|
245
|
931
|
8gwkA |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
|
20
|
76
|
8gwkC |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
|
100
|
592
|
8gwkE |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
|
94
|
592
|
8gwmE |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
|
14
|
113
|
8gwmG |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
|
46
|
187
|
8gwmB |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
|
18
|
113
|
8gwkG |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
|
43
|
187
|
8gwkB |
Sars-cov-2 rna e-rtc complex with rmp-nsp9 and gmppnp |
|
21
|
72
|
8gwmC |
Sars-cov-2 e-rtc bound with mmp-nsp9 and gmppnp |
|
95
|
296
|
8rzdA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 9 |
|
99
|
296
|
8rzcA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 11 |
|
28
|
115
|
8rzeB |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 10 |
|
28
|
115
|
8rzdB |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 9 |
|
98
|
296
|
8rzeA |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 10 |
|
29
|
116
|
8rzcB |
Sars-cov-2 nsp16-nsp10 in complex with sam derivative inhibitor 11 |
|
93
|
305
|
8cdcA |
Native 3clpro from sars-cov-2 at 1.54 a |
|
88
|
305
|
8tpbA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
87
|
305
|
8tphA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
87
|
305
|
8tpeA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
28
|
114
|
8tyjB |
Crystal structure of sars-cov-2 nsp10/nsp16 complex with bound sah |
|
82
|
305
|
8tpiA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
95
|
296
|
8tyjA |
Crystal structure of sars-cov-2 nsp10/nsp16 complex with bound sah |
|
84
|
305
|
8tpfA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
87
|
305
|
8tpcA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
89
|
305
|
8tpdA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
83
|
305
|
8tpgA |
Synthesis, x-ray crystallographic and biological activities of covalent, non-peptidic inhibitors of sars-cov-2 main protease |
|
85
|
299
|
8hvoA |
Crystal structure of sars-cov-2 main protease v186f mutant in complex with pf07321332 |
